SCHEMBL6173294

SCHEMBL6173294

CCNc1cnccc1CC1(C)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
AOC1 P19801 1/20 0.37
AOC3 Q16853 1/20 0.37
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
FLT1 P17948 4/20 0.35
KDR P35968 4/20 0.35
AR P10275 3/20 0.35
TRPV1 Q8NER1 1/20 0.34
LIPE Q05469 2/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
CCR9 P51686 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173183 0.91 CYP3A4 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172191 0.88 AOC1 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6171757 0.87 CYP3A4 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6176657 0.86 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175495 0.86 CYP3A4 (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173695 0.85 ITGAL (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175766 0.84 AOC1 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172435 0.84 POLB (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174775 0.84 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6207150 0.84 CCR9 (0.44) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed